We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Leica Microsystems Acquires Labindia’s Microscopy and Histopathology Divisions

By LabMedica International staff writers
Posted on 15 Nov 2011
In a move set to boost growth with a local presence in India, Leica Microsystems (Wetzlar, Germany) acquired the microscopy and histopathology divisions of Labindia Instruments Pvt. More...
Ltd. (Thane, India).

This move comes after more than 20 years during which Labindia has successfully distributed Leica’s products in India. Over 130 associates from Labindia have transferred to Leica Microsystems to sustain continuity for existing customers who will continue to benefit from Labindia’s experience of their needs and applications. The acquisition is the culmination of a long partnership, and supports Leica Microsystems’ strategy to expand its operations in India.

“Leica Microsystems’ expansion of its commercial operations in India creates extended opportunities for interaction, collaboration, and innovation to benefit all of our customers in the life sciences, industrial laboratories and hospitals for both diagnostics and surgery,” explains Arnd Kaldowski, president Leica Microsystems. “This acquisition will enable closer contact with our customers so that we can better support them in their day-to-day work.”

Vijay Bibikar, director Labindia, commented, “We are convinced that at this point in time this agreement is a logical further step in the long history of close cooperation between Labindia and Leica Microsystems and that it will be beneficial to all our customers.” Says Kaldowski: “We highly appreciate the work that our partner Labindia has done driving our business in India to its present high level. We are excited about the future potential of the Indian market and the potential to help our customers to meet with their professional challenges.”

Leica Microsystems is a world leader in microscopes and scientific instruments. Leica Microsystems is organized in four divisions: the Life Science Division, Industry Division, Biosystems Division, and Medical Division. Leica Microsystems’ Biosystems Division, also known as Leica Biosystems offers histopathology laboratories a product range for each step in histology and for high levels of productivity in the working processes. The company is represented in over 100 countries with 12 manufacturing facilities in 7 countries, sales and service organizations in 19 countries, and an international network of dealers.

Related Links:
Leica Microsystems
Labindia Instruments


Gold Member
Troponin T QC
Troponin T Quality Control
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Quality Control Material
Multichem ID-B
New
Automatic Hematology Analyzer
LABAS F9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.